Quantcast
Last updated on April 18, 2014 at 8:18 EDT

Latest Erectile dysfunction Stories

2014-02-26 16:26:01

DUBLIN, February 26, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/khhjl8/erectile) has announced the addition of the "Erectile Dysfunction Drugs Market - Forecast to 2019" [http://www.researchandmarkets.com/research/khhjl8/erectile ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The erectile dysfunction drugs market is expected to witness a decline across the globe, by the end of the...

2014-02-25 08:30:54

CHESTERBROOK, Pa., Feb. 25, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced that certain members of the executive management team will participate in the Cowen and Company 34(th) Annual Healthcare Conference to be held March 3-5, 2014 at the Boston Marriott Copley Place Hotel in Boston. Adrian Adams, Chief Executive Officer and President, is scheduled to present an overview of the Company and...

2014-02-19 23:00:12

Research Study Testing Effectiveness of New Outpatient Treatment for Localized Prostate Cancer Royal Oak, MI (PRWEB) February 20, 2014 Urologists at Beaumont Hospital, Royal Oak are first in the U.S. to treat localized prostate cancer with a transurethral ultrasound therapy guided by magnetic resonance imaging. The experimental treatment is designed to potentially reduce the long-term complications of traditional prostate cancer treatments. The first treatment on Jan. 25 marked the launch...

2014-02-19 08:29:55

-Company Marks Milestone of Two New Product Launches- CHESTERBROOK, Pa., Feb. 19, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, will ring the Opening Bell at the NASDAQ MarketSite in Times Square, New York at 9:30 a.m. ET on February 26, 2014 to celebrate Auxilium's transformation into a leading men's healthcare company, including two recent launches of new products in men's healthcare, XIAFLEX®...

2014-02-05 08:28:25

CHESTERBROOK, Pa., Feb. 5, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced that certain members of the executive management team will participate in the Leerink Swann Global Healthcare Conference to be held February 11-13, 2014 at the Waldorf Astoria Hotel in New York. Adrian Adams, Chief Executive Officer and President, is scheduled to participate in a discussion about the Company at 10:40...

2014-01-10 00:20:36

LAKEWOOD, Calif., Jan. 9, 2014 /PRNewswire-USNewswire/ -- Dr. Jonathan E. Perley, of Lakewood Regional Medical Center will be speaking to the community on the following subjects. Erectile Dysfunction in MenMedical Options for erectile dysfunction with special emphasis on the surgical treatment options for men whose ED is a side effect of prostate cancer treatment, diabetes or heart disease.Monday, Jan 13, 2014; 1-2pm: Cerritos Senior Center12340 South St, Cerritos, CA 90701 Urinary...

2014-01-08 08:27:31

CHESTERBROOK, Pa., Jan. 8, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced that the executive management team will participate in the J.P. Morgan 32(nd) Annual Healthcare Conference to be held January 13-16, 2014 at the Westin St. Francis Hotel in San Francisco. Adrian Adams, Chief Executive Officer and President, is scheduled to present an overview of the Company and its product portfolio at 4...

2014-01-07 08:30:12

Dr. Elist, a seasoned Beverly Hills urologist, presented a novel, 510(K) cleared device to increase penile length and girth safely, effectively, and with long lasting results LOS ANGELES, Jan. 7, 2014 /PRNewswire/ -- The Sexual Medicine Society of North America (SMSNA) reviewed and embraced a revolutionary procedure for male penile enhancement by Dr. James Elist (www.drelist.com) during their November 2013 conference. Read the article here:...

2013-12-27 04:21:44

DUBLIN, December 27, 2013 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/3zf33c/erectile) have announced the addition of the "Global Erectile Dysfunction Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" [http://www.researchandmarkets.com/research/3zf33c/erectile ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Erectile dysfunction (ED) is the...

2013-12-13 12:23:58

Spin-Off Positions Ampio to Focus on its Core Inflammatory Assets GREENWOOD VILLAGE, Colo., Dec. 13, 2013 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that it has spun off its sexual dysfunction business into a standalone company called Vyrix Pharmaceuticals, Inc. The new Company is expected to be funded through an initial public offering. (Logo: http://photos.prnewswire.com/prnh/20120516/MM09116LOGO) Vyrix' assets will include Zertane and...